Autologous immunotherapy for human leukemias

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 1, 2003, Pages 121-124

  Claxton, David ^a   Kao, Shing Fen ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 4; VACCINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN PRESENTATION; BLOOD AUTOTRANSFUSION; CELL DIFFERENTIATION; CLINICAL PROTOCOL; CYTOTOXICITY; DENDRITE; DENDRITIC CELL; DRUG POTENCY; EFFECTOR CELL; HUMAN; IMMUNITY; IMMUNOTHERAPY; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; SCALE UP;

EID: 0038690072     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00120-7     Document Type: Article

References (13)

1. Matulonis U.A., Dosiou C., Lamont C., Freeman G.J., Mauch P., Nadler L.M., Griffin J.D. Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood. 85:1995;2507-2515.
2. Choudhury A., Gajewski J.L., Liang J.C., Popat U., Claxton D.F., Kliche K.O., Andreeff M., Champlin R.E. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood. 89:1997;1133-1142.
3. Charbonnier A., Gaugler B., Sainty D., Lafage-Pochitaloff M., Olive D. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur. J. Immunol. 29:1999;2567-2578.
4. Fujii S., Fujimoto K., Shimizu K., Ezaki T., Kawano F., Takatsuki K., Kawakita M., Matsuno K. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients . Cancer Res. 59:1999;2150-2158.
5. Hagihara M., Shimakura Y., Tsuchiya T., Ueda Y., Gansuvd B., Munkhbat B., Chargui J., Ando K., Kato S., Hotta T. The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro. Leukemia Res. 25:2001;249-258.
6. Kohler T., Plettig R., Wetzstein W., Schmitz M., Ritter M., Mohr B., Schaekel U., Ehninger G., Bornhauser M. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells. 18:2000;139-147.
7. Pawlowska A.B., Hashino S., McKenna H., Weigel B.J., Taylor P.A., Blazar B.R. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice. Blood. 97:2001;1474-1482.
8. Choudhury A., Liang J.C., Thomas E.K., Flores-Romo L., Xie Q.S., Agusala K., Sutaria S., Sinha I., Champlin R.E., Claxton D.F. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood. 93:1999;780-786.
9. Woiciechowsky A., Regn S., Kolb H.J., Roskrow M. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia. Leukemia. 15:2001;246-255.
10. Caux C., Massacrier C., Vanbervliet B., Dubois B., Durand I., Cella M., Lanzavecchia A., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha II. Functional analysis . Blood. 90:1997;1458-1470.
11. Pickl W.F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 157:1996;3850-3859.
12. Riddell S.R., Greenberg P.D. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods. 128:1990;189-201.
13. Molldrem J.J., Lee P.P., Wang C., Felio K., Kantarjian H.M., Champlin R.E., Davis M.M. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat. Med. 6:2000;1018-1023.